Boehringer’s Smith Discusses The Challenges Of Diabetes At ADA
This article was originally published in The Pink Sheet Daily
Executive Summary
Relatively new to the diabetes space, Boehringer Ingelheim is trying to rapidly distinguish itself in a crowded field with four products each addressing a different patient need.